Showing results (11-20 of 377) with videos related to
Sort By:
Pageof 38
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 18, 2025
The Nara Declaration: A New Collaborative Flow for Chronic Liver Disease Between Primary Care Physicians and Gastroenterologists/HepatologistsTakumi Kawaguchi, Hitoshi Yoshiji, Satoshi Mochida, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 31, 2024
Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction-associated steatotic liver diseaseMasahito Nakano, Machiko Kawaguchi, Takumi Kawaguchi, et al.Current Cancer Drug Targets|December 8, 2004
Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapyHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 19, 2020
The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitisTadashi Namisaki, Yukihisa Fujinaga, Kei Moriya, et al.World Journal of Gastroenterology|November 21, 2007
Eosinophilic cholecystitis as a rare manifestation of visceral larva migransHitoshi Yoshiji, Masahide Yoshikawa, Kosuke Kaji, et al.Current Drug Abuse Reviews|July 28, 2009
Recent developments in the treatment of alcoholic chronic pancreatitisTatsuhiro Tsujimoto, Hideto Kawaratani, Hitoshi Yoshiji, et al.Oncology Reports|February 12, 2005
Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in miceHitoshi Yoshiji, Ryuichi Noguchi, Shigeki Kuriyama, et al.Hepatic Medicine : Evidence and Research|July 18, 2018
Management of refractory cirrhotic ascites: challenges and solutionsHiroshi Fukui, Hideto Kawaratani, Kosuke Kaji, et al.Cancer Letters|March 7, 2002
Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenograftsSteven R Harris, Daniel J Schoeffner, Hitoshi Yoshiji, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 27, 2023
Safety and effectiveness of lusutrombopag in patients who have chronic liver disease with thrombocytopenia and undergoing invasive procedures: Real-world post-marketing surveillance in JapanHitoshi Yoshiji, Junto Suzuki, Masafumi Imasaki, et al.Pageof 38